TREK Diagnostic Systems Opens New UK Facility in East Grinstead to Meet ... PR-AU.com... Kangaroo News Service - TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand f
PR-AU.com... Kangaroo News Service
* Contacts
Home Tasmania TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand f
Saturday, 21 November 2009
Areas
Victoria
New South Wales
Queensland
South Australia
Northern Territory
Western Australia
Tasmania
Capital Territory
Other
Login
Username
Remember me
Lost Password?
If you want to publish a PR, you need to Register
Most Read of the day
* TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand f
* Hispanics Minding Money in Downturn Without Sacrificing Pleasures, C&R Research Finds
* Tube City IMS Opens Trading Office in Taiwan
* Optiant Updates PowerChain 6.2 With Features That Increase Performance & Add More Complex Demand Sce
* T-Mobile Complete(R) ofrece flexibilidad y conveniencia a los consumidores hispanos con los nuevos p
* Landacorp Releases First-Ever Proven, Large-Scale Care Management System
* Canadian Scholars Analyze U.S. Employee Free Choice Act, Debunk Criticisms of Canadian Labour Market
* Iowa Governor Chet Culver to Deliver Keynote Address at Midwest Clean Tech 2009
* TCPI's 11th Annual Symposium Takes on Tax Reform in the 21st Century
* Day 3 WISE 2009: Peer-to-Peer Digital Communications Also Have Central Role in Education Practices
* 1.2 Million Michiganians To Travel During Thanksgiving, Says AAA
* MicroPact, Inc. Selects Boscobel to Provide Public Relations
* Hengdeli and LVMH Watch & Jewelry Division Announce Renewal of Strategic Alliance
* Bunker Hill Community College Will Tweet to Recruit
* Improving Quality, Cost-Effectiveness, and Time Savings in Preclinical Inhalable Formulation Develop
* Residential Hospitality Services, Inc. Adds NoHo 14 Apartments
* Luxury Vacations for Bargain Prices at RockBottomVacations.com
* Tampa Bay Federal Credit Union Now Offers FHA Loans
* Michael Creech Joins Bureau Veritas to Manage the North American Industry Division
* iShares China A-Share ETF Series Records Total Turnover of HKD 100M on First Trading Day
* Limited Brands Reports Third Quarter 2009 Earnings
* Lexington Realty Trust Resumes Cash Dividend
* Foot Locker, Inc. Declares Quarterly Dividend of $0.15 Per Share
* Belden Declares Regular Quarterly Dividend
* Pizza Hut(R) iPhone App Wins Two MMA Awards
* MyFit Closes $1 Million Series A Led by NEA
* Rhode Island Couple Sentenced to Prison for Tax Evasion
* NASA Astronaut Headed to 'The Swamp'
* Foot Locker, Inc. Elects Ken C. Hicks to Additional Position of Chairman of the Board
* The Steeltown FILM FACTORY Is Now Open!
Disclaimer
Privacy Policy
TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand f
TREK Diagnostic Systems, a Magellan Biosciences business and premier provider of diagnostic systems and susceptibility products for microbiology labs, has expanded its East Grinstead, U.K., manufacturing and research and development facility to meet increasing global demand for its Sensititre. product line for susceptibility and identification testing. The expanded facility has been fully validated, and will continue to deliver the same high-quality Sensititre products, including the popular Sensititre microbroth dilution plates used in clinical and veterinary microbiology laboratories worldwide.
Just a short distance from TREK's original U.K. location, the new facility at Units 17 - 19 Birches Industrial Estate, East Grinstead, manufactures standard and custom susceptibility plates. Customers use these plates to determine what drugs and dosage levels are required to treat bacterial and yeast infections. Since the tests match the treatment course with the appropriate drugs, this helps address the growing problem of drug resistance.
More than 100 people, including East Grinstead Town Councillor Bob Mainstone, representatives from U.K. Trade and Investment and the town government, TREK employees and their families, attended a grand-opening celebration on Monday, hosted by President of Magellan Clinical Diagnostics, James Whelan. The event included a ribbon-cutting ceremony, site tour, and fun, learn-about-microbiology activities for children.
"We outgrew our previous facility thanks to increasing demand for our expanding line of susceptibility products, which provide our customers with the cost-effective, and reliable microbiology results they need to make more-informed treatment decisions," said James Whelan. "The proliferation of drug-resistant infections means that clinicians and infection-control experts are looking to us to increase reportable and non-reportable compounds and treatment options that they can evaluate. We have a number of new IVD and RUO plates in development that we hope to launch in 2010, including a Mycobacterium tuberculosis susceptibility plate for first- and second-line drugs."
During his remarks, Mr. Whelan spoke of TREK's decision to build the new facility in East Grinstead, "We have been a part of the community here for more than 30 years, and we're proud of our seasoned, experienced workforce. So when it came time to choose a location where we could expand, East Grinstead was the natural choice. Our new facility gives us the capacity to meet customer needs and allows for future expansion." Currently, 69 of TREK's 180 employees work at the East Grinstead location.
Commenting on the expansion, U.K. Minister for Trade, Investment and Small Business Lord Davies of Abersoch said in a statement, "The U.K. not only has the largest pharmaceuticals industry in Europe, it is also the number one location in Europe for R&D. Globally, one in five of the world's medicines were developed in the U.K. Although the U.K. accounts for just three percent of the global pharmaceutical market, we attract 10 percent of its R&D. I warmly welcome Magellan Bioscience's decision to expand its operations in the U.K. and look forward to hearing more about its successes."
Over the past 18 months, TREK has introduced a number of new in vitro diagnostics (IVD) plates, including a GRAM positive plate used in MRSA detection, which is FDA-cleared for D-Test and Cefoxitin screening; YeastOne plates available with five IVD-cleared antifungal compounds: itraconazole, fluconazole, 5-flucytosine, voriconazole and caspofungin; as well as new plates for research use only (RUO).
About the Sensititre Product Line
TREK's signature Sensititre product line for susceptibility and identification testing enables labs to test -- on a single cost-effective, LIS-compatible system -- more FDA-cleared antimicrobial drugs than on any other automated platform against the widest range of non-fastidious and fastidious bacteria and yeasts. This saves microbiology labs from having to use multiple off-line test procedures to obtain accurate susceptibility data. In order to increase reportable compounds and treatment options for clinicians, TREK obtains FDA clearance where feasible and appropriate. TREK often gets early access to the latest therapeutics because pharmaceutical companies use the Sensititre system during drug development. TREK's platform is also the system-of-choice for global surveillance initiatives, including NARMS (National Antimicrobial Resistance Monitoring System). TREK offers a full range of standard and custom Sensititre plates featuring 18- to 24-hour incubation, true MIC endpoints, and on-scale QC ranges, making susceptibility testing a viable procedure for virtually any size laboratory. The Vizion. system adds easy-to-read digital imaging capability to take the guesswork out of reading susceptibility results. Small minimum order quantities allow for better cost and inventory control. To learn more about custom plates, call customer service toll-free at 800 871-8909. Outside the US and Canada, dial +44 (0) 1342-318777 or e-mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
About TREK Diagnostic Systems (www.trekds.com)
A Magellan Biosciences clinical-diagnostics business dedicated to serving the unique needs of microbiology customers, TREK Diagnostic Systems is a premier provider of advanced systems and consumables for blood culture and antimicrobic-susceptibility testing. Hospital-based, reference, and other microbiology labs trust our products to identify pathogens in patients' blood, and to determine what antimicrobial therapies are effective against them. Clinical, research, pharmaceutical, and veterinary customers count on our staff's microbiology expertise, lab-process savvy, and reliable support to help them address the serious and growing problem of drug-resistant infections. We deliver our advanced technology worldwide as flexible solutions that provide fast, consistent results, while reducing lab and pharmacy costs and improving patient care. Headquartered in Cleveland, Ohio, TREK has additional facilities in Sun Prairie, Wisconsin, and East Grinstead, U.K.
Source: TREK Diagnostic Systems
{ Prev
Next }
[ Back ]
Hot News
* CRWE NEWSWIRE Release from StockHotTips.com On MTCH
* Spike in Unemployment Hits 10.2% worst since 1983 brought to you by StockHotTips.com
* Study Proves Fluoride in Water = Money Wasted
* Possible Novel H1N1 Cases in Pigs Not Unexpected; Experts Say U.S. Pork Is Safe to Eat
* U.S. Army Corps of Engineers to Open First of Three Recovery Act-Funded Veterans Curation Project La
Impressive
* Ipera Technology Accelerates High-Volume Video Transcoding With Launch of Pixel Xtream v2
* Gibson Dunn Promotes 11 Lawyers to Partner for 2010
* Remarks as Prepared for Delivery by Attorney General Eric Holder Before the Senate Judiciary Committ
* Detroit Students Gain Competitive Edge Through Youth Entrepreneurship Training
* Brean Murray, Carret & Co. China Gaming and Media Conference
* New Report Reveals Disappointment and Disengagement Among Illinois Citizens
* SequentialT Launches a Global Business and Social Movement
* eVoter(TM) Launches in Illinois for the February 2010 Primary Election
* St. Louis Fed's Bullard Discusses 'The First Phase of the U.S. Recovery'
* Pennsylvania Department of Health Offers Resources to Help Smokers Quit During 'Great American Smoke
* U.S. Department of State Launches Second Annual ExchangesConnect Video Contest to Amplify U.S. Publi
* Global Trust Council Launches New Website
* Littlebanc Completes Sale of South Florida Educational Software Company to Phoenix Strategy Investme
* California Bipolar Foundation Seeds Huge NIMH Grant
* Unions Fight to Avoid Layoffs as County Passes Sales Tax Rollback
* St. Kitts' Port Zante Can Accommodate the World's Largest Cruise Ship
* Honda Personal-Neo Urban Transport Concept to Debut in Los Angeles
* Bringing Sustainability to a New Generation: Green Schools Summit & Expo Coming Soon
* Magellans.com Signs Three Year Agreement With Warp 9
* Boy Scouts of America to Bring World-Class Scouting Venue to West Virginia
* YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENT
* (ISC)2(R) to Expand Government Information Security Leadership Awards (GISLAs) in 2010
* Houston-based Green's Blue Flame Joins Alliance AutoGas to Provide Propane Vehicle Conversions and F
* China aposta na America Latina
* Albireo gibt positive klinische Ergebnisse mit A3309 bei Patienten mit chronischer idiopathischer Ko
* EpsteinBeckerGreen Only Firm To Rank In Top 20 In Recent Surveys Of Both Law Firm Client Service And
* Foster Hinshaw Takes the Helm at Dataupia
* Wale's Attention: Deficit Debut Album Scores an Attention-Getting First Week
* Albireo annuncia dati clinici positivi su A3309 in pazienti con costipazione idiopatica cronica
* Experts to Discuss What President Obama's Trip to China Will Mean For Jobless Workers in America
(c) 2009 PR-AU.com... Kangaroo News Service
Joomla! is Free Software released under the GNU/GPL License.
I thought this page was interesting because:
| re:2.57 st:0.01 fo:0 s:0.01 d:2.41 c:0 db:0.054 a:0.93 m:0.36 t:7.48 (f) |
| ![:-] Bot! - home](/bot/images/dsbotface1.gif ":-] Bot! - home")
